A股收評:三大指數小幅下跌,算力、廣電概念等升幅居前
A股主要指數今日震盪走弱,截至收盤,滬指跌0.23%報3371點,深證成指跌0.17%,創業板指跌0.58%。全天成交1.73萬億元,較前一交易日增量2057億元,全市場超2600股上升。盤面上,算力概念走高,朗科科技20%升停;廣電概念活躍,江蘇有線、廣西廣電等多股升停;電源設備板塊拉昇,麥克米特升停;《神經系統醫療服務價格項目立項指南》發佈,其中專門為腦機接口新技術單獨立項,腦機接口板塊活躍,創新醫療升停;發電機概念走強,泰豪科技等多股升停;高壓快充、智能電視及盲盒經濟等板塊升幅居前。另外,海南板塊走低,雙成藥業跌停;生物製品板塊下挫,海創藥業跌超13%;航天航空、免疫治療及雞肉概念等跌幅居前。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.